Cargando…
GABARAPL1 suppresses metastasis by counteracting PI3K/Akt pathway in prostate cancer
Metastasis remains the primary cause of prostate cancer (CaP)-related death. Using a genome wide shRNA screen, we identified GABARAPL1 as a potential CaP metastasis suppressor. GABARAPL1 mRNA levels inversely correlate with the invasive potential of a panel of human CaP cell lines. Lower mRNA levels...
Autores principales: | Su, Wei, Li, Shibao, Chen, Xiaofan, Yin, Lingyu, Ma, Ping, Ma, Yingyu, Su, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354845/ https://www.ncbi.nlm.nih.gov/pubmed/27966458 http://dx.doi.org/10.18632/oncotarget.13879 |
Ejemplares similares
-
GABARAPL1 Promotes AR+ Prostate Cancer Growth by Increasing FL-AR/AR-V Transcription Activity and Nuclear Translocation
por: Su, Bing, et al.
Publicado: (2019) -
A Genome-Wide RNAi Screen Identifies FOXO4 as a Metastasis-Suppressor through Counteracting PI3K/AKT Signal Pathway in Prostate Cancer
por: Su, Bing, et al.
Publicado: (2014) -
EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression
por: Li, Shibao, et al.
Publicado: (2015) -
Knockout of Akt1/2 suppresses the metastasis of human prostate cancer cells CWR22rv1 in vitro and in vivo
por: Su, Bing, et al.
Publicado: (2020) -
Cinnamaldehyde Suppressed EGF-Induced EMT Process and Inhibits Ovarian Cancer Progression Through PI3K/AKT Pathway
por: Wang, Yue, et al.
Publicado: (2022)